| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |